By Nick Paul Taylor – Fierce Biotech –
The FDA has stopped new clinical trials that export American citizens’ living cells from the U.S. to “China and other hostile countries for genetic engineering and subsequent infusion” back into American patients.
Officials said they took the action in response to “mounting evidence that some of these trials failed to inform participants about the international transfer and manipulation of their biological material and may have exposed Americans’ sensitive genetic data to misuse by foreign governments.” The statement about the ban on new trials contains no examples of such activities.
